Skip to content

NovaEvum research news

This week in research.

Every week we read the newly published PubMed papers on the peptides we supply, from BPC-157 and TB-500 to tirzepatide, retatrutide and MOTS-c, and write up what each study examined, with a link to the paper itself.

Latest · Week of 9 November 2026

This Week in Research: Tirzepatide, BPC-157, MOTS-c and Thymosin Alpha-1

Nine new papers on compounds we carry crossed our desk this week, and the most useful ones are the least flashy. Three on tirzepatide ask what happens after the headline result: what it does to the gut's bacteria, what happens to body weight when people stop, and a hospital case that raises a new safety question. There is a BPC-157 review on the liver, a large ICU cohort on thymosin alpha-1, an athlete study on MOTS-c, and two reviews that put retatrutide, tesamorelin and copper peptides in context. What follows is our read of what each one examined and how far it goes.

Read all 9 papers

Earlier weeks

Looking for background on a compound? The research library has an article on each one.